Jefferies Upgrades AveXis (AVXS) to Buy

August 12, 2016 6:47 AM EDT
Get Alerts AVXS Hot Sheet
Price: $51.20 -0.66%

Rating Summary:
    5 Buy, 1 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 30 | Down: 30 | New: 23
Trade AVXS Now!
Join SI Premium – FREE

Get the Pulse of the Market with's Pulse Picks. Get your Free Trial here.

Jefferies upgraded AveXis (NASDAQ: AVXS) from Hold to Buy with a price target of $42.00.

Analyst Biren Amin commented, "AVXS reported updated SMA Type 1 data today in conjunction with earnings. The data continued to show no events in the therapeutic dose cohort and improving CHOP-INTEND scores. With this continued efficacy data along w/ positive feedback from an expert dinner suggesting that FDA may allow for a single-arm pivotal trial in SMA Type 1, we are upgrading to Buy."

For an analyst ratings summary and ratings history on AveXis click here. For more ratings news on AveXis click here.

Shares of AveXis closed at $34.80 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Upgrades

Related Entities

Jefferies & Co, Earnings

Add Your Comment